QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9 作者:  Wei, Qing;  Yuan, Xing;  Li, Jingjing;  Xu, Qi;  Ying, Jieer 收藏  |  浏览/下载：31/0  |  提交时间：2020/11/30 Programmed death 1 (PD-1)  gastric cancer (GC)  immune checkpoint inhibitors  immunotherapy  apatinib   Repurposing cabozantinib to GISTs: Overcoming multiple imatinib-resistant cKIT mutations including gatekeeper and activation loop mutants in GISTs preclinical models 期刊论文 CANCER LETTERS, 2019, 页码: 105-114 作者:  Lu, Tingting;  Chen, Cheng;  Wang, Aoli;  Jiang, Zongru;  Qi, Ziping 收藏  |  浏览/下载：16/0  |  提交时间：2020/07/14 cKIT T670I mutant  Activation loop mutants  Drug resistance   Efficacy and safety of Endostar (recombinant human endostatin hormone) combined with docetaxel as second-or third-line therapy for patients with non-small-cell lung cancer 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 卷号: 10, 期号: 1 作者:  Ji, Dongmei;  Wang, Jialei;  Yu, Hui;  Wu, Xianghua;  Wang, Huijie 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Carcinoma  non-small-cell lung  chemotherapy  second or third line therapy  endostar protein  docetaxel   A phase II trial of biweekly vinorelbine and oxaliplatin in second-or third-line metastatic triple-negative breast cancer 期刊论文 CANCER BIOLOGY & THERAPY, 2015, 卷号: 16, 期号: 2 作者:  Zhang, Jian;  Wang, Leiping;  Wang, Zhonghua;  Hu, Xichun;  Wang, Biyun 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 chemotherapy  metastatic breast cancer  oxaliplatin  triple-negative  vinorelbine